Improved Tumor Targeting with cRGD Peptide in Mice
Author Information
Author(s): Jin Zhao-Hui, Josserand Véronique, Foillard Stéphanie, Boturyn Didier, Dumy Pascal, Favrot Marie-Christine, Coll Jean-Luc
Primary Institution: INSERM, U823, Cibles Diagnostiques ou Thérapeutiques et Vectorisation des Drogues dans le Cancer du Poumon, Institut Albert Bonniot, France
Hypothesis
The study aimed to demonstrate how a tetrameric presentation of cRGD improves targeting potential in vivo.
Conclusion
The study confirmed that the tetrameric Cy5-RAFT-c(-RGDfK-)4 binds more effectively to the αVβ3 receptor than its monomeric counterpart.
Supporting Evidence
- The tetrameric Cy5-RAFT-c(-RGDfK-)4 showed significantly higher tumor uptake compared to the monomeric cRGD.
- Blocking studies confirmed the specificity of the tetramer for the αVβ3 integrin.
- The tumor/skin ratio reached values above 15, indicating excellent contrast for imaging.
Takeaway
Researchers found that a special molecule can help doctors see tumors better in mice by sticking to them more effectively than a simpler version.
Methodology
The study used in vivo optical imaging techniques to compare the uptake of Cy5-RAFT-c(-RGDfK-)4 and its monomeric analog in tumor-bearing mice.
Participant Demographics
Female athymic Swiss nude mice, 6–8 weeks old.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website